AJP - Regu AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (November 30, 2006). doi:10.1152/ajpregu.00734.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/4/R1391    most recent
00734.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Degen, L.
Right arrow Articles by Beglinger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Degen, L.
Right arrow Articles by Beglinger, C.
Submitted on October 18, 2006
Accepted on November 23, 2006

Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in man

Lukas Degen1, Juergen Drewe2, Franziska Piccoli1, Karin Gräni1, Sibylle Oesch1, Raluca Bunea1, Massimo D'Amato3, and Christoph Beglinger1*

1 Gastroenterology and Clinical Research Center, University Hospital, Basel, Switzerland
2 Clinical Pharmacology, University Hospital, Basel, Switzerland
3 Clinical Pharmacology, Rotta Pharma SpA, Monza, Italy

* To whom correspondence should be addressed. E-mail: beglinger{at}tmr.ch.

Background an Aim. Cholecystokinin (CCK), peptide YY (PYY) and ghrelin have been proposed to act as satiety hormones. CCK and PYY are stimulated during meal intake by the presence of nutrients in the small intestine, especially fat, whereas ghrelin is inhibited by eating. The sequence of events (fat intake followed by fat hydrolysis and CCK release) suggests that this process is crucial for triggering the effects. The aim of this study was therefore to investigate whether CCK mediated the effect of intraduodenal (ID) fat on ghrelin secretion and PYY release via CCK-1 receptors. Methods: 36 male volunteers were studied in three consecutive, randomized, double blind, cross-over studies. 1) 12 subjects received an ID fat infusion with or without 120 mg orlistat, an irreversible inhibitor of gastrointestinal lipases, in comparison to vehicle. 2) 12 subjects received ID long chain fatty acids (LCF), ID medium chain fatty acids (MCF) or ID vehicle. 3) 12 subjects received ID LCF with and without the CCK-1 receptor antagonist dexloxiglumide (DEXLOX) or ID vehicle plus iv saline (placebo). ID infusions were given for 180 min. The effect of these treatments on ghrelin concentrations and PYY release was quantified. Plasma hormone concentrations were measured in regular intervals by specific RIA systems. Results: 1) ID fat induced a significant inhibition in ghrelin levels (p<0.01) and a significant increase in PYY concentrations (p<0.004). Inhibition of fat hydrolysis by orlistat abolished both effects. 2) LCF significantly inhibited ghrelin levels (p<0.02) and stimulated PYY release (p<0.008), whereas MCF were ineffective compared to controls. 3) DEXLOX administration abolished the effect of LCF on ghrelin and on PYY. ID fat or LCF significantly stimulated plasma CCK (p<0.006 and p<0.004) compared to saline. MCF did not stimulate plasma CCK release. Summary: Fat hydrolysis is essential to induce effects on ghrelin and PYY through the generation of LCF; MCF are ineffective. LCF furthermore stimulated plasma CCK release suggesting that peripheral CCK is the mediator of these actions. The CCK-1 receptor antagonist DEXLOX abolished the effect of ID LCF, both on ghrelin and PYY. Conclusion: Generation of LCF through hydrolysis of fat is a critical step for fat-induced inhibition of ghrelin and stimulation of PYY in humans; the signal is mediated via CCK release and CCK-1 receptors.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. Y. Enc, T. Ones, H. L. Akin, F. Dede, H. T. Turoglu, G. Ulfer, N. Bekiroglu, G. Haklar, J. F. Rehfeld, J. J. Holst, et al.
Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects
Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G482 - G489.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. R. Juvonen, A.-K. Purhonen, M. Salmenkallio-Marttila, L. Lahteenmaki, D. E. Laaksonen, K.-H. Herzig, M. I. J. Uusitupa, K. S. Poutanen, and L. J. Karhunen
Viscosity of Oat Bran-Enriched Beverages Influences Gastrointestinal Hormonal Responses in Healthy Humans
J. Nutr., March 1, 2009; 139(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. M. Brennan, T. J. Little, K. L. Feltrin, A. J. P. M. Smout, J. M. Wishart, M. Horowitz, and C. Feinle-Bisset
Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men
Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1487 - E1494.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
B. J. Bradford, K. J. Harvatine, and M. S. Allen
Dietary Unsaturated Fatty Acids Increase Plasma Glucagon-Like Peptide-1 and Cholecystokinin and May Decrease Premeal Ghrelin in Lactating Dairy Cows
J Dairy Sci, April 1, 2008; 91(4): 1443 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Little, K. L. Feltrin, M. Horowitz, J. H. Meyer, J. Wishart, I. M. Chapman, and C. Feinle-Bisset
A high-fat diet raises fasting plasma CCK but does not affect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R45 - R51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Hao, C. Sternini, and H. E. Raybould
Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R33 - R38.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.